tradingkey.logo
tradingkey.logo
Search

Precision BioSciences Inc

DTIL
Add to Watchlist
6.990USD
-0.010-0.14%
Close 07-31 16:00ETQuotes delayed by 15 min
180.36MMarket Cap
LossP/E TTM

DTIL Income Statement

You can find the annual or quarterly income statement of Precision BioSciences Inc here for insights into the performance and operational efficiency of Precision BioSciences Inc.
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
FY2021Q1
FY2020Q4
FY2020Q3
FY2020Q2
FY2020Q1
FY2019Q4
FY2019Q3
FY2019Q2
FY2019Q1
FY2018Q4
FY2018Q3
FY2018Q2
FY2018Q1
FY2017Q4
Total revenue
37272.41%10.84M
5261.13%34.20M
-97.74%13.00K
-99.96%18.00K
-99.84%29.00K
-90.93%638.00K
-95.61%576.00K
152.15%49.90M
100.27%17.58M
-33.59%7.04M
78.19%13.12M
418.04%19.79M
164.70%8.78M
67.19%10.60M
-69.37%7.36M
-94.45%3.82M
-79.71%3.32M
-28.34%6.34M
226.44%24.04M
6282.65%68.81M
133.62%16.35M
35.63%8.85M
51.35%7.36M
-80.00%1.08M
28.12%7.00M
32.02%6.52M
91.46%4.87M
187.57%5.39M
257.46%5.46M
224.15%4.94M
--2.54M
--1.87M
--1.53M
--1.52M
Revenue
37272.41%10.84M
5261.13%34.20M
-97.74%13.00K
-99.96%18.00K
-99.84%29.00K
-90.93%638.00K
-95.61%576.00K
152.15%49.90M
100.27%17.58M
-33.59%7.04M
78.19%13.12M
418.04%19.79M
164.70%8.78M
67.19%10.60M
-69.37%7.36M
-94.45%3.82M
-79.71%3.32M
-28.34%6.34M
226.44%24.04M
6282.65%68.81M
133.62%16.35M
35.63%8.85M
51.35%7.36M
-80.00%1.08M
28.12%7.00M
32.02%6.52M
91.46%4.87M
187.57%5.39M
257.46%5.46M
224.15%4.94M
--2.54M
--1.87M
--1.53M
--1.52M
Operating expenses
-10.06%19.91M
-14.86%21.70M
-5.36%20.68M
-14.98%21.89M
1.70%22.14M
16.22%25.48M
-14.25%21.85M
12.37%25.75M
-1.64%21.77M
-3.43%21.93M
15.63%25.48M
-31.33%22.92M
-27.79%22.13M
-38.73%22.71M
-38.05%22.04M
-29.25%33.37M
-12.65%30.65M
14.65%37.06M
6.50%35.58M
39.21%47.17M
1.73%35.09M
13.89%32.33M
24.45%33.41M
15.81%33.89M
38.22%34.49M
34.87%28.38M
106.68%26.84M
109.01%29.26M
131.87%24.96M
133.29%21.05M
--12.99M
--14.00M
--10.76M
--9.02M
R&D expenses
-3.13%12.83M
-6.75%14.46M
4.39%13.04M
-24.08%12.44M
6.39%13.25M
24.84%15.51M
-15.84%12.49M
35.44%16.38M
24.69%12.45M
6.31%12.43M
38.53%14.85M
-43.22%12.10M
-45.49%9.99M
-52.57%11.69M
-55.41%10.72M
-39.52%21.30M
-22.90%18.32M
15.81%24.64M
4.55%24.04M
51.11%35.23M
3.13%23.76M
15.50%21.28M
22.95%22.99M
6.63%23.31M
19.73%23.04M
12.34%18.42M
92.04%18.70M
108.74%21.86M
148.15%19.24M
134.20%16.40M
--9.74M
--10.47M
--7.75M
--7.00M
Depreciation, depletion, and amortization
-24.30%299.00K
-16.96%377.00K
-51.05%350.00K
-65.38%378.00K
-65.44%395.00K
-64.50%454.00K
-55.86%715.00K
-44.43%1.09M
-41.47%1.14M
-34.74%1.28M
-16.54%1.62M
1.87%1.96M
-0.76%1.95M
-9.89%1.96M
-14.27%1.94M
-18.47%1.93M
-9.56%1.97M
-0.68%2.17M
1.57%2.26M
7.40%2.37M
0.97%2.18M
21.06%2.19M
59.10%2.23M
88.61%2.20M
129.50%2.15M
126.41%1.81M
139.49%1.40M
128.13%1.17M
105.02%939.00K
84.10%799.00K
--585.00K
--512.00K
--458.00K
--434.00K
Operating profit
58.96%-9.07M
150.34%12.51M
2.86%-20.67M
-190.60%-21.88M
-428.11%-22.11M
-66.86%-24.85M
-72.09%-21.27M
871.68%24.15M
68.65%-4.19M
-22.97%-14.89M
15.76%-12.36M
89.41%-3.13M
51.15%-13.35M
60.59%-12.11M
-27.15%-14.68M
-236.62%-29.55M
-45.85%-27.34M
-30.85%-30.72M
55.68%-11.54M
165.94%21.63M
31.84%-18.74M
-7.41%-23.48M
-18.50%-26.04M
-37.44%-32.81M
-41.05%-27.50M
-35.74%-21.86M
-110.38%-21.98M
-96.87%-23.87M
-111.09%-19.49M
-114.82%-16.11M
---10.45M
---12.13M
---9.23M
---7.50M
Net non-operating interest income (expenses)
Non-operating interest income
-24.49%999.00K
-48.26%773.00K
-41.75%1.03M
-39.45%1.12M
-20.44%1.32M
-18.23%1.49M
-5.72%1.76M
-5.29%1.84M
-18.60%1.66M
-5.68%1.83M
59.56%1.87M
913.54%1.95M
1087.79%2.04M
2974.60%1.94M
2563.64%1.17M
300.00%192.00K
224.53%172.00K
133.33%63.00K
57.14%44.00K
-55.14%48.00K
-91.97%53.00K
-97.14%27.00K
-97.73%28.00K
-92.79%107.00K
9.82%660.00K
42.75%945.00K
78.87%1.24M
396.66%1.48M
169.51%601.00K
184.12%662.00K
--691.00K
--299.00K
--223.00K
--233.00K
Non-operating interest expense
-12.15%311.00K
-11.22%348.00K
41.41%362.00K
-36.07%358.00K
-38.33%354.00K
-32.30%392.00K
-55.56%256.00K
1.27%560.00K
9.96%574.00K
19.14%579.00K
42.22%576.00K
210.67%553.00K
1142.86%522.00K
816.98%486.00K
636.36%405.00K
641.67%178.00K
--42.00K
--53.00K
--55.00K
--24.00K
----
--0.00
----
----
-100.00%0.00
--0.00
--0.00
--0.00
--182.00K
----
----
--0.00
--0.00
----
Return on equity
-100.00%0.00
-452.47%-5.37M
32.46%-591.00K
30.00%-665.00K
-21.66%1.34M
-11.60%-972.00K
35.19%-875.00K
30.61%-950.00K
227.74%1.71M
-133.45%-871.00K
24.24%-1.35M
5.46%-1.37M
-40.86%-1.34M
1315.22%2.60M
---1.78M
---1.45M
---952.00K
--184.00K
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Special income (expenses)
-1232.19%-10.06M
68.81%12.07M
-128.02%-1.18M
-120.23%-1.71M
-107.52%-755.00K
346.23%7.15M
1256.27%4.22M
--8.46M
1405.33%10.04M
114.12%1.60M
--311.00K
--0.00
---769.00K
-237.36%-11.35M
-100.00%0.00
--0.00
--0.00
--8.27M
--274.00K
----
----
----
----
----
100.00%0.00
--0.00
--0.00
--2.95M
---12.71M
100.00%0.00
----
--0.00
----
---118.00K
- Gains from disposal of fixed assets
144.44%4.00K
-114.29%-390.00K
--3.00K
86.77%-25.00K
86.15%-9.00K
65.27%-182.00K
100.00%0.00
-362.50%-189.00K
-828.57%-65.00K
-2657.89%-524.00K
---2.00K
253.19%72.00K
36.36%-7.00K
26.92%-19.00K
--0.00
---47.00K
---11.00K
---26.00K
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Income before tax
10.33%-18.44M
208.47%19.25M
-32.55%-21.77M
-171.82%-23.52M
-339.46%-20.57M
-32.09%-17.75M
-35.63%-16.43M
1179.76%32.75M
161.56%8.59M
30.85%-13.43M
22.82%-12.11M
90.23%-3.03M
50.48%-13.95M
12.84%-19.43M
-39.12%-15.69M
-243.31%-31.04M
-50.72%-28.17M
4.96%-22.29M
56.65%-11.28M
166.22%21.66M
30.36%-18.69M
-12.13%-23.45M
-25.43%-26.02M
-68.25%-32.70M
15.56%-26.84M
-35.44%-20.92M
-112.61%-20.74M
-64.35%-19.44M
-252.67%-31.78M
-109.20%-15.44M
---9.76M
---11.83M
---9.01M
---7.38M
Income tax
----
--0.00
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Income after tax
10.33%-18.44M
208.47%19.25M
-32.55%-21.77M
-171.82%-23.52M
-339.46%-20.57M
-32.09%-17.75M
-35.63%-16.43M
1179.76%32.75M
161.56%8.59M
30.85%-13.43M
22.82%-12.11M
90.23%-3.03M
50.48%-13.95M
12.84%-19.43M
-39.12%-15.69M
-243.31%-31.04M
-50.72%-28.17M
4.96%-22.29M
56.65%-11.28M
166.22%21.66M
30.36%-18.69M
-12.13%-23.45M
-25.43%-26.02M
-68.25%-32.70M
15.56%-26.84M
-35.44%-20.92M
-112.61%-20.74M
-64.35%-19.44M
-252.67%-31.78M
-109.20%-15.44M
---9.76M
---11.83M
---9.01M
---7.38M
Net income from continuous operations
10.33%-18.44M
208.47%19.25M
-32.55%-21.77M
-171.82%-23.52M
-339.46%-20.57M
-32.09%-17.75M
-35.63%-16.43M
1179.76%32.75M
161.56%8.59M
30.85%-13.43M
22.82%-12.11M
90.23%-3.03M
50.48%-13.95M
12.84%-19.43M
-39.12%-15.69M
-243.31%-31.04M
-50.72%-28.17M
4.96%-22.29M
56.65%-11.28M
166.22%21.66M
30.36%-18.69M
-12.13%-23.45M
-25.43%-26.02M
-68.25%-32.70M
15.56%-26.84M
-35.44%-20.92M
-112.61%-20.74M
-64.35%-19.44M
-252.67%-31.78M
-109.20%-15.44M
---9.76M
---11.83M
---9.01M
---7.38M
Net income from discontinued operations
----
--885.00K
----
----
----
----
-100.00%0.00
100.00%0.00
100.00%0.00
68.49%-2.85M
148.83%4.03M
---8.86M
---11.11M
---9.06M
---8.26M
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Net income attributable to controlling interests
10.33%-18.44M
213.46%20.13M
-32.55%-21.77M
-171.82%-23.52M
-339.46%-20.57M
-8.94%-17.75M
-103.30%-16.43M
375.41%32.75M
134.27%8.59M
42.82%-16.29M
66.26%-8.08M
61.69%-11.89M
11.03%-25.06M
-27.81%-28.49M
-112.31%-23.95M
-243.31%-31.04M
-50.72%-28.17M
4.96%-22.29M
56.65%-11.28M
166.22%21.66M
30.36%-18.69M
-12.13%-23.45M
-25.43%-26.02M
-68.25%-32.70M
15.56%-26.84M
-35.44%-20.92M
-112.61%-20.74M
-64.35%-19.44M
-252.67%-31.78M
-109.20%-15.44M
---9.76M
---11.83M
---9.01M
---7.38M
Net income attributable to common shareholders
10.33%-18.44M
213.46%20.13M
-32.55%-21.77M
-171.82%-23.52M
-339.46%-20.57M
-8.94%-17.75M
-103.30%-16.43M
375.41%32.75M
134.27%8.59M
42.82%-16.29M
66.26%-8.08M
61.69%-11.89M
11.03%-25.06M
-27.81%-28.49M
-112.31%-23.95M
-243.31%-31.04M
-50.72%-28.17M
4.96%-22.29M
56.65%-11.28M
166.22%21.66M
30.36%-18.69M
-12.13%-23.45M
-25.43%-26.02M
-68.25%-32.70M
15.56%-26.84M
-35.44%-20.92M
-112.61%-20.74M
-64.35%-19.44M
-252.67%-31.78M
-109.20%-15.44M
---9.76M
---11.83M
---9.01M
---7.38M
Basic earnings per share
66.18%-0.75
147.52%1.05
18.27%-1.84
-145.29%-2.13
-230.42%-2.21
45.43%-2.22
-7.10%-2.25
250.35%4.70
125.12%1.70
47.17%-4.06
67.53%-2.10
77.18%-3.13
51.21%-6.75
30.24%-7.69
-14.26%-6.48
-221.77%-13.70
-39.84%-13.85
17.71%-11.02
61.96%-5.67
159.54%11.25
36.89%-9.90
65.66%-13.39
-21.30%-14.91
-62.17%-18.90
17.13%-15.69
-312.62%-38.99
-105.92%-12.29
-61.05%-11.65
-243.34%-18.93
-109.20%-9.45
---5.97
---7.24
---5.51
---4.52
Diluted earnings per share
66.18%-0.75
147.52%1.05
18.27%-1.84
-145.59%-2.13
-230.49%-2.21
45.43%-2.22
-7.10%-2.25
249.38%4.67
125.11%1.70
47.17%-4.06
67.53%-2.10
77.18%-3.13
51.21%-6.75
30.24%-7.69
-14.26%-6.48
-226.20%-13.70
-39.84%-13.85
17.71%-11.02
61.96%-5.67
157.45%10.86
36.89%-9.90
65.66%-13.39
-21.30%-14.91
-62.17%-18.90
17.13%-15.69
-312.62%-38.99
-105.92%-12.29
-61.05%-11.65
-243.34%-18.93
-109.20%-9.45
---5.97
---7.24
---5.51
---4.52
Dividend per share
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Currency unit
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
Audit opinions
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----

FAQs

How do I read Precision BioSciences Inc's income statement on TradingKey?

Start with total revenue, then review cost of revenue, gross profit, operating expenses, operating profit, income before tax, net income, and EPS. Revenue shows the scale of the business, while margins and profit lines show whether that revenue is being converted into earnings efficiently.

What is the difference between quarterly and annual income statements?

A quarterly income statement shows performance for a three-month fiscal period, while an annual income statement summarizes the full fiscal year. Quarterly data is useful for tracking recent momentum and seasonality, while annual data is better for judging long-term growth, profitability, and business cycles.

What does YOY mean on the income statement page?

YOY means year over year. It compares a financial metric with the same period in the previous year, such as this quarter's revenue versus revenue in the same quarter last year. YOY comparison helps investors see growth trends while reducing the impact of normal seasonal changes.

Which income statement metrics matter most when analyzing DTIL stock?

Important metrics include revenue growth, gross profit, gross margin, operating profit, operating margin, net income, EPS, R&D expenses, SG&A expenses, and tax expense. Investors usually look at these together to judge whether the company is growing, controlling costs, and improving profitability.

What was Precision BioSciences Inc's revenue at year end?

Precision BioSciences Inc reported 34.26M in revenue for fiscal year 2025, up from 68.70M in the previous year.

How much revenue did Precision BioSciences Inc report in the most recent quarter?

Precision BioSciences Inc reported 10.84M in revenue for the most recent quarter, an increase of 37272.41% year over year.

What was Precision BioSciences Inc's net income for the year?

Precision BioSciences Inc posted -45.72M in net income for fiscal year 2025.

How much net income did Precision BioSciences Inc post in the last quarter?

Precision BioSciences Inc reported -18.44M in net income for the latest quarter。

What was Precision BioSciences Inc's annual operating profit?

Precision BioSciences Inc's operating income was -52.15M for fiscal year 2025.

How is EPS related to the income statement?

EPS, or earnings per share, is based on net income divided by the number of shares outstanding. It helps investors understand how much profit the company generated for each share, but it should be reviewed alongside share count changes, margins, cash flow, and valuation metrics.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.